Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 7,748	$ 5,143
General and administrative	4,103	4,589
Total operating expenses	11,851	9,732
Loss from operations	(11,851)	(9,732)
Other income (expense), net:
Interest and investment income	756	687
Other income (expense), net	756	687
Net loss	$ (11,095)	$ (9,045)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.97)	$ (0.8)
Weighted-average shares outstanding, basic (in Shares)	11,420,948	11,303,869
Other comprehensive income (loss):
Net unrealized gain (loss) on marketable debt securities	$ 30	$ 219
Other comprehensive income (loss)	30	219
Comprehensive loss	$ (11,065)	$ (8,826)